查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605868

藥物研發AI市場，規模，佔有率，趨勢，產業分析報告:各提供，各技術，各治療領域，各用途，各終端用戶，各地區 - 市場預測 2025年～2034年

AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2034 年，藥物發現 AI 市場預計將達到 264.9779 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於技術進步的快速採用、醫療保健需求的增加以及製藥業不斷發展的動態，藥物發現人工智慧市場正在經歷快速成長。對更高效、更具成本效益的藥物開發流程的需求不斷增長，正在推動對藥物發現人工智慧市場的需求。傳統的藥物發現方法往往耗時且成本高昂，且在臨床試驗過程中失敗率很高。人工智慧透過加速識別潛在候選藥物、預測療效和安全性以及優化臨床試驗設計來提供解決方案。這減少了與藥物開發相關的時間和成本，有助於市場開發。此外，慢性病的流行和對個人化醫療日益增長的需求正在推動藥物發現解決方案對人工智慧的需求。隨著人口老化以及癌症、糖尿病和心血管疾病等疾病發病率的增加，對新的、更有效的治療方法的需求日益增長。人工智慧技術，包括機器學習和深度學習，特別適合分析大型資料集並識別使用傳統方法可能不明顯的模式。這種能力將使開發針對個別患者情況的針對性治療成為可能，從而改善治療結果並減少副作用。

公共和私營部門的大量投資推動了藥物發現人工智慧的採用。世界各地的政府和醫療保健組織正在認識到人工智慧徹底改變藥物發現過程的潛力，並投資研發計畫以加速創新。此外，人工智慧技術公司與製藥巨頭之間的合作也在不斷增加，旨在將人工智慧融入藥物開發的各個階段。這些合作得到了運算能力、雲端運算和大數據分析的進步進一步支持，為藥物發現人工智慧應用提供了必要的基礎設施。

藥物發現人工智慧市場報告亮點

到2024 年，由於對創新癌症治療的高需求以及癌症研究的複雜性，腫瘤學領域將在藥物發現人工智慧市場中佔據最大的收入佔有率，這極大地受益於人工智慧驅動的解決方案。

據預測，隨著人工智慧技術的採用加速藥物發現、降低開發成本並提高藥物開發過程的準確性和效率，製藥和生物技術公司部門將以最快的複合年增長率增長。

2024 年，在先進的醫療基礎設施、對人工智慧研究的高額投資以及大型製藥公司利用人工智慧進行藥物開發的推動下，北美在藥物發現人工智慧市場中佔據最大的市場佔有率。技術公司的存在。

亞太地區在預測期內將出現最快的複合年增長率，因為其龐大且多樣化的患者群體提供了寶貴的數據和政府支持措施，以促進預計將增長的藥物發現創新。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 藥物研發AI市場世界的洞察

  • 應用概述
  • 藥物研發市場動態
    • 促進因素和機會
      • 製藥公司與人工智慧提供者之間的合作將推動市場成長
      • 人工智慧技術的進步正在推動市場成長。
    • 抑制因素和挑戰
      • 資料隱私和安全問題限制了藥物發現人工智慧市場的成長
  • PESTEL分析
  • 藥物研發市場上AI的應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 藥物研發AI市場世界的趨勢:各提供

  • 主要調查結果
  • 簡介
  • 軟體
  • 服務

第6章 全球藥物研發AI市場:各技術

  • 主要調查結果
  • 簡介
  • 機器學習
  • 其他的科技

第7章 全球藥物研發AI市場:各治療領域

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 神經退化性疾病
  • 心血管疾病
  • 代謝性疾病
  • 感染疾病
  • 其他

第8章 全球藥物研發AI市場:各用途

  • 主要調查結果
  • 簡介
  • 醫藥品的最佳化與再利用
  • 臨床試驗前
  • 其他

第9章 全球藥物研發AI市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 製藥·生物科技企業
  • 契約調查機關
  • 研究中心
  • 學術機構及政府機關

第10章 全球藥物研發AI市場:各地區

  • 主要調查結果
  • 簡介
    • 藥物研發AI市場評估:各地區，2020～2034年
  • 北美
    • 北美:各提供，2020～2034年
    • 北美:各技術，2020～2034年
    • 北美:各治療領域，2020年～2034年
    • 北美:各用途，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各提供，2020～2034年
    • 歐洲:各技術，2020～2034年
    • 歐洲:各治療領域，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各提供，2020年～2034年
    • 亞太地區:各技術，2020～2034年
    • 亞太地區:各治療領域，2020年～2034年
    • 亞太地區:各用途，2020～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各提供，2020～2034年
    • 中東·非洲:各技術，2020～2034年
    • 中東·非洲:各治療領域，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各提供，2020～2034年
    • 南美:各技術，2020～2034年
    • 南美:各治療領域，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第11章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第12章 企業簡介

  • Atomwise Inc.
  • BenevolentAI
  • Berg Health
  • BioSymetrics, Inc.
  • CYCLICA
  • Exscientia
  • GNS Healthcare
  • Google
  • IBM
  • Insilico Medicine
  • insitro
Product Code: PM1850

The AI in drug discovery market size is expected to reach USD 26,497.79 million by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.

The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.

AI in Drug Discovery Market Report Highlights

In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.

The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.

In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.

The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.

The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.

Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:

By Offering Outlook (Revenue - USD million, 2020-2034)

  • Software
  • Services

By Technology Outlook (Revenue - USD million, 2020-2034)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Therapeutic Area Outlook (Revenue - USD million, 2020-2034)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

By Application Outlook (Revenue - USD million, 2020-2034)

  • Drug optimization & repurposing
  • Preclinical testing
  • Others

By End User Outlook (Revenue - USD million, 2020-2034)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers
  • Academic & Government Institutes

By Regional Outlook (Revenue - USD million, 2020-2034)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Drug Discovery Market Insights

  • 4.1. AI in Drug Discovery Market - Application Snapshot
  • 4.2. AI in Drug Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
      • 4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Drug Discovery Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Drug Discovery Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2020-2034 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2020-2034 (USD Million)

6. Global AI in Drug Discovery Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2020-2034 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2020-2034 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.4. Reinforcement Learning
      • 6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2020-2034 (USD Million)
    • 6.3.5. Unsupervised Learning
      • 6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2020-2034 (USD Million)
  • 6.4. Other Technologies
    • 6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2020-2034 (USD Million)

7. Global AI in Drug Discovery Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • 7.3. Oncology
    • 7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2020-2034 (USD Million)
  • 7.4. Neurodegenerative Diseases
    • 7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD Million)
  • 7.5. Cardiovascular Disease
    • 7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Million)
  • 7.6. Metabolic Diseases
    • 7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2020-2034 (USD Million)
  • 7.7. Infectious Disease
    • 7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2020-2034 (USD Million)
  • 7.8. Others
    • 7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

8. Global AI in Drug Discovery Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • 8.3. Drug optimization & repurposing
    • 8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2020-2034 (USD Million)
  • 8.4. Preclinical testing
    • 8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2020-2034 (USD Million)
  • 8.5. Others
    • 8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

9. Global AI in Drug Discovery Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 9.3. Pharmaceutical & Biotechnology Companies
    • 9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
  • 9.4. Contract Research Organizations
    • 9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
  • 9.5. Research Centers
    • 9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2020-2034 (USD Million)
  • 9.6. Academic & Government Institutes
    • 9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2020-2034 (USD Million)

10. Global AI in Drug Discovery Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2020-2034 (USD Million)
  • 10.3. AI in Drug Discovery Market - North America
    • 10.3.1. North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.3.2. North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.3.4. North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.3.5. North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.7. AI in Drug Discovery Market - U.S.
      • 10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.8. AI in Drug Discovery Market - Canada
      • 10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.4. AI in Drug Discovery Market - Europe
    • 10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.4.4. Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.4.5. Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.6. AI in Drug Discovery Market - UK
      • 10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.7. AI in Drug Discovery Market - France
      • 10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.7.4. France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.7.5. France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.8. AI in Drug Discovery Market - Germany
      • 10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.9. AI in Drug Discovery Market - Italy
      • 10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.10. AI in Drug Discovery Market - Spain
      • 10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.11. AI in Drug Discovery Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.12. AI in Drug Discovery Market - Russia
      • 10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.13. AI in Drug Discovery Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.5. AI in Drug Discovery Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.6. AI in Drug Discovery Market - China
      • 10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.6.4. China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.6.5. China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.7. AI in Drug Discovery Market - India
      • 10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.7.4. India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.7.5. India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.8. AI in Drug Discovery Market - Malaysia
      • 10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.9. AI in Drug Discovery Market - Japan
      • 10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.10. AI in Drug Discovery Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.11. AI in Drug Discovery Market - South Korea
      • 10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.12. AI in Drug Discovery Market - Australia
      • 10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.6. AI in Drug Discovery Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.6. AI in Drug Discovery Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.7. AI in Drug Discovery Market - UAE
      • 10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.8. AI in Drug Discovery Market - Israel
      • 10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.9. AI in Drug Discovery Market - South Africa
      • 10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.7. AI in Drug Discovery Market - Latin America
    • 10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.6. AI in Drug Discovery Market - Mexico
      • 10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.7. AI in Drug Discovery Market - Brazil
      • 10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.8. AI in Drug Discovery Market - Argentina
      • 10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.9. AI in Drug Discovery Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Atomwise Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BenevolentAI
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Berg Health
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. BioSymetrics, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. CYCLICA
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Exscientia
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GNS Healthcare
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Google
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. IBM
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Insilico Medicine
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. insitro
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development

List of Tables:

  • Table 1 Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 2 Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 3 Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 4 Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 5 Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 6 North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 7 North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 8 North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 9 North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 10 North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 11 U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 12 U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 13 U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 14 U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 15 U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 16 Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 17 Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 18 Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 19 Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 20 Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 21 Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 22 Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 23 Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 25 Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 26 UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 27 UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 28 UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 29 UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 30 UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 31 France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 32 France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 33 France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 34 France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 35 France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 36 Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 37 Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 38 Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 39 Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 40 Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 41 Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 42 Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 43 Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 44 Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 45 Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 46 Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 47 Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 48 Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 49 Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 50 Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 51 Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 52 Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 53 Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 54 Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 55 Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 56 Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 57 Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 58 Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 59 Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 60 Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 71 China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 72 China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 73 China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 74 China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 75 China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 76 India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 77 India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 78 India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 79 India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 80 India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 81 Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 82 Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 83 Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 85 Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 86 Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 87 Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 88 Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 89 Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 90 Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 91 Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 92 Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 93 Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 94 Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 95 Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 96 South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 97 South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 98 South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 99 South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 100 South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 101 Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 102 Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 103 Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 104 Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 105 Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 121 UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 122 UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 123 UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 124 UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 125 UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 126 Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 127 Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 128 Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 129 Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 130 Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 131 South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 132 South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 133 South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 134 South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 135 South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 141 Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 142 Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 143 Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 144 Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 145 Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 146 Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 147 Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 148 Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 149 Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 150 Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 151 Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 152 Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 153 Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 154 Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 155 Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 156 Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 157 Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 158 Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 159 Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 160 Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global AI in Drug Discovery Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Drug Discovery Market, by Offering, 2024 & 2034 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Drug Discovery Market, by Technology, 2024 & 2034 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global AI in Drug Discovery Market, by Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global AI in Drug Discovery Market, by Application, 2024 & 2034 (USD Million)
  • Figure 14. Market by End User
  • Figure 15. Global AI in Drug Discovery Market, by End User, 2024 & 2034 (USD Million)